Novo Nordisk Must Face Fraud Lawsuit Over CagriSema Trial, Judge Rules

3-line summary

• A judge ruled that Novo Nordisk must face a fraud lawsuit over its CagriSema clinical trial, according to the report.

This summary is our own processing of the source article; see the source link below for full context.